Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 80.49 USD 0.2% Market Closed
Market Cap: 13B USD

Wall Street
Price Targets

IONS Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast IONS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IONS is 87.25 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.

Lowest
Price Target
46.46 USD
42% Downside
Average
Price Target
87.25 USD
8% Upside
Highest
Price Target
115.5 USD
43% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
MDXH
MDxHealth SA
107% Upside
CHRS
Coherus BioSciences Inc
331% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside
GILD
Gilead Sciences Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Ionis Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 4 years is 27%.

16%
Past Growth
27%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IONS's stock price target?
Price Target
87.25 USD

According to Wall Street analysts, the average 1-year price target for IONS is 87.25 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.

What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
27%

For the last 13 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 4 years is 27%.

Back to Top